Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction >35.
Abbasin ZegardOsita OkaforJoseph de BonoManish KallaMauro LencioniHoward MarshallLucy HudsmithTian QiuRichard Paul SteedsBerthold StegemannFrancisco LeyvaPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
In CAD patients with an LVEF >35%, GZF3SD mass was strongly associated with the arrhythmic endpoint. These findings hold promise for its use in identifying patients with CAD and an LVEF >35% at risk of arrhythmic events.
Keyphrases
- left ventricular
- ejection fraction
- aortic stenosis
- coronary artery disease
- hypertrophic cardiomyopathy
- heart failure
- cardiac resynchronization therapy
- left atrial
- acute myocardial infarction
- mitral valve
- big data
- percutaneous coronary intervention
- congenital heart disease
- machine learning
- transcatheter aortic valve replacement
- deep learning